On September 6, 2019 Medigene AG (FSE: MDG1, Prime Standard) reported its participation at the following upcoming scientific and investor conferences. Medigene’s management and/or scientists will be available for one-on-one meetings at these events.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

CAR TCR Summit
Date: 10 – 13 September 2019
Location: Boston, USA

DG-GT Theme Day "CAR-T cells and beyond"
Date: 16 – 17 September 2019
Location: Leipzig, Germany

Berenberg Bank and Goldman Sachs German Corporate Conference
Date: 23 – 25 September 2019
Location: Munich, Germany

ESMO – European Society for Medical Oncology Congress
Date: 27 September – 01 October 2019
Location: Barcelona, Spain

On September 6, 2019 Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis ("OM"), reported that Alan Joslyn, president and CEO of Oragenics, Inc. will be a featured presenter at the 21st Annual Rodman and Renshaw Global Investment Conference on Tuesday September 10, 2019 at 3:25 PM Eastern Time (Press release, Oragenics, SEP 6, 2019, View Source [SID1234539357]). The conference is being held at the Lotte New York Palace Hotel in New York City.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Joslyn will provide a Company update and will be available for one-on-one meetings. Interested investors may request a meeting time by contacting John Marco, at CORE IR, either by calling 516-222-2560 or via [email protected].

On Septemner 6, 2019 Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) reported that its management will be presenting at and attending the following upcoming conferences (Press release, Evotec, SEP 6, 2019, View Source;announcements/press-releases/p/evotec-to-attend-upcoming-investor-conferences-5845 [SID1234539355]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

J.P. Morgan Cazenove Pan-European Small/Mid Cap Conference, London, UK

Date: Wednesday, 11 September 2019
Venue: London, UK
Attendee: Enno Spillner, Chief Financial Officer

Bank of America Merrill Lynch Global Healthcare Conference 2019, London, UK

Date: Wednesday, 18 September 2019,
Presentation: 18 September 2019, 4.25 pm BST
Venue: London, UK
Attendee: Werner Lanthaler, Chief Executive Officer

Baader Investment Conference, Munich, Germany

Date: Monday, 23 September 2019,
Presentation: 23 September 2019, 5.15 pm CEST
Venue: Munich, Germany
Attendee: Enno Spillner, Chief Financial Officer

Berenberg and Goldman Sachs Eighth German Corporate Conference, Munich, Germany

Date: Tuesday, 24 September 2019,
Presentation: 24 September 2019, 2.30 pm CEST
Venue: Munich, Germany
Attendee: Enno Spillner, Chief Financial Officer

Ladenburg Thalmann Healthcare Conference, New York, NY, USA

Date: Tuesday, 24 September 2019,
Presentation: 24 September 2019, 10.30 am EDT
Venue: New York, NY, USA
Attendee: Dr Werner Lanthaler, Chief Executive Officer

2019 Cantor Global Healthcare Conference, New York, NY, USA

Date: Wednesday, 02 October 2019,
Presentation: 02 October 2019, 3.00 pm EDT
Venue: New York, NY, USA
Attendee: Dr Werner Lanthaler, Chief Executive Officer

On September 6, 2019 AbbVie Inc. (NYSE: ABBV) reported that declared a quarterly cash dividend of $1.07 per share.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The cash dividend is payable November 15, 2019 to stockholders of record at the close of business on October 15, 2019.

Since the company’s inception in 2013, AbbVie has increased its dividend by 168 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

On September 6, 2019 Dr. Reddy’s Laboratories Ltd (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) announced that the Company will be presenting at the Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10th, 2019, in New York City.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Erez Israeli, Global CEO will present at Fireside Chat session at 10:35 a.m. ET [8:05 p.m. IST on September 10th, 2019].